Gateway Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Gateway Advisory's PFE Position: Q3 2024 in Review
Gateway Advisory reduced its Pfizer (PFE) stake by 15% in Q3 2024, selling an estimated $44K and leaving 8,429 shares worth $244K. The position accounts for 0.04% of the portfolio, ranked #127.
Gateway Advisory first reported a position in PFE in Q2 2016 and has held it in 24 quarters since. The position peaked at $387K in Q4 2022. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Gateway Advisory held 8,429 shares of Pfizer worth $244K as of Q3 2024.
- Gateway Advisory sold 1,507 Pfizer shares in Q3 2024, an estimated $44K.
- Pfizer made up 0.04% of Gateway Advisory's portfolio in Q3 2024, its #127 holding.
- Gateway Advisory first reported a position in Pfizer in Q2 2016 and has held it in 24 quarters since.
- Gateway Advisory's Pfizer position peaked at $387K in Q4 2022.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Gateway Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.